Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEAK PROCESSING LIMITED Board/Management Information 2018

Sep 26, 2018

65568_rns_2018-09-26_04dd37f1-1faf-4658-b509-41eab0c8ba12.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [113 x 72] intentionally omitted <==

FOR IMMEDIATE RELEASE

Althea appoints Chief Financial Officer and General Counsel

Melbourne, Australia, 27 September 2018: Medicinal Cannabis company Althea Group Holdings Limited (“Althea”) (ASX:AGH) today announces the appointment of Robert Meissner as Chief Financial Officer and David Sauer as General Counsel.

Robert Meissner’s appointment as Chief Financial Officer (CFO) – effective 15 October 2018 – follows Althea’s recent successful listing on the ASX. Mr Meissner brings over 13 years’ experience in financial and commercial roles and he is currently Financial Controller at Village Roadshow Entertainment Group.

Mr Meissner is tasked with leading the planning, implementation and execution of all Althea’s financial activities as well as investor relations.

“I was drawn to Althea for the opportunity to assist in driving an Australian company’s vision of making medicinal cannabis more accessible to patients across the country, and the excellent strategy to get there,” said Mr Meissner.

David Sauer, Althea’s General Counsel as of 29 October 2018, will manage the provision of legal, risk and compliance services, utilising his six years of Legal Counsel experience at CPA Australia.

Mr Sauer was instrumental in providing counsel to Althea’s founders during the early stages of its IPO preparations, and his appointment as General Counsel of Althea will be an asset to the company moving forward.

Althea CEO Joshua Fegan said: “We are thrilled to welcome Robert and David to Althea’s leadership team. These appointments build upon our strong foundation of expertise and will support us in executing on our three-stage business model, enabling us to focus on improving patient access and education for doctors and pharmacists.”

For more information about Althea visit www.althea.com.au

-ENDS-

Background information

Althea was founded in Melbourne in 2017 with a view to acquiring the necessary licences and permits to import, cultivate, produce and supply medicinal cannabis for eligible patients across Australia. Through strategic supply and distribution partnerships, Althea has been able to commence sales of five Althea branded medicinal cannabis products in Australia.

==> picture [113 x 72] intentionally omitted <==

Althea’s focus on patient care underpins its business strategy and its innovative web-based platform and mobile application, known as Althea Concierge, is designed to educate and support patient access to medicinal cannabis in Australia. Althea has also engaged a team of medical science liaisons to assist medical practitioners to become prescribers, and pharmacists to become suppliers, of Althea products.

Media contacts:

Mandy Caplan, Keep Left on behalf of Althea 03 9268 7800 | [email protected]

Georgia Harrison, Keep Left on behalf of Althea

03 9268 7800 | [email protected]

Investors:

PAC Partners Securities

03 8633 9834 | [email protected]

Althea:

Joshua Fegan, CEO and Managing Director 1300 70 20 20 | [email protected]